Epitomee Medical Ltd / Fundamentals

    Income statement

    Net revenue
    €973.03M
    Cost of goods sold
    €495.86K
    Gross profit
    €972.54M
    SG&A expenses
    €263.55M
    R&D expenses
    €431.99M
    EBITDA
    -€163.68M
    D&A
    €19.16M
    EBIT
    -€244.92M
    Interest expenses
    €763.84K
    EBT
    -€558.73M
    Tax expenses
    €24.06M
    Net income
    -€558.73M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€173.61M
    Changes in working capital
    €21.58K
    Operating cash flow
    -€590.47M
    Capex
    €205.15M
    Other investing cash flow
    €889.12M
    Net investing cash flow
    €381.20M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €42.60K
    Debt repayment
    €0.00
    Other financing cash flow
    -€39.85M
    Net financing cash flow
    -€31.71M
    Foreign exchange effects
    -€25.98M
    Net change in cash
    -€120.99M
    Cash at end of period
    €12.57M
    Free cash flow
    -€385.33M

    Balance sheet

    Cash and cash equivalents
    €3.28M
    Cash and short-term investments
    €7.63M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €107.14K
    Total current assets
    €7.74M
    Property, plant & equipment
    €1.45M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €70.73K
    Total non-current assets
    €1.52M
    Total assets
    €9.26M
    Accounts payable
    €157.96K
    Short-term debt
    €134.91K
    Other current liabilities
    €194.90K
    Total current liabilities
    €487.77K
    Long-term debt
    €971.08K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €971.08K
    Total liabilities
    €1.46M
    Common stock
    €23.62M
    Retained earnings
    -€17.01M
    Other equity
    €0.00
    Total equity
    €7.80M
    Total liabilities and shareholders' equity
    €9.26M

    Company information

    Market capitalization
    €257.16M
    Employees
    42
    Enterprise Value
    €236.62M

    Company ratios

    Gross margin
    99.9%
    EBITDA margin
    -16.8%
    EBIT margin
    -25.2%
    EBT margin
    -57.4%
    Net margin
    -57.4%
    ROE
    -7,160.0%
    ROA
    -6,032.3%
    Asset turnover
    10,505.3%
    FCF margin
    -81.8%
    FCF yield
    -309.4%
    Efficiency ratio
    116.8%
    Net sales per employee
    €23.17M
    Net income per employee
    -€13.30M

    Notifications